Internship

Intern – Clinical Operations

Confirmed live in the last 24 hours

Tarsus Pharamceuticals

Tarsus Pharamceuticals

201-500 employees

Develops treatments for eye care diseases

Biotechnology
Healthcare

Compensation Overview

$44Hourly

Irvine, CA, USA

This position is hybrid, requiring some in-office presence.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets

You match the following Tarsus Pharamceuticals's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Graduate student in the health sciences field (such as biotechnology management, biological sciences, chemistry, etc) within two years of graduation
  • Strong project management, organizational, and problem-solving skills
  • Ability and demonstrated previous experience in critically analyzing complex ideas
  • Strong communication skills and ability to adapt to changing project needs
  • Proficient in basic computer programs such as Microsoft Excel, Word, and PowerPoint
Responsibilities
  • Contribute to the operations aspect of clinical management, which may include taking part in vendor meetings, developing investigator/site materials, instructional materials for patients, etc.
  • Prepare clinical trial training materials such as PowerPoint presentations, instructional materials for sites, etc.
  • Assist with operational process flow.
  • Organize and archive clinical study documentation within the Trial Master File.
  • Interact with various departments such as Clinical Development/Regulatory/CMC etc. to gain exposure to the collaborative development process associated with executing a clinical trial.
  • General administrative support to the department and study managers as needed.
Tarsus Pharamceuticals

Tarsus Pharamceuticals

View

Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution used to treat Demodex Blepharitis, a condition affecting the eyelids. The company also has a pipeline of potential treatments for other conditions, including Lyme Disease Prevention and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong commitment to ethical practices and compliance. Their goal is to improve patient outcomes by providing effective treatments for conditions that currently have limited options.

Company Stage

IPO

Total Funding

$58.4M

Headquarters

Irvine, California

Founded

2017

Growth & Insights
Headcount

6 month growth

5%

1 year growth

1%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing awareness of Demodex blepharitis expands market for Tarsus's XDEMVY.
  • Telemedicine rise offers new marketing opportunities for Tarsus's products.
  • FDA's focus on unmet needs may expedite Tarsus's pipeline approvals.

What critics are saying

  • Increased competition in ophthalmic treatments challenges Tarsus's market position.
  • Potential clinical trial delays could affect Tarsus's product pipeline.
  • Supply chain constraints may hinder XDEMVY's production and distribution.

What makes Tarsus Pharamceuticals unique

  • Tarsus focuses on high unmet needs in ophthalmic and infectious diseases.
  • Their lead product, XDEMVY, is FDA-approved for Demodex blepharitis treatment.
  • Tarsus's pipeline includes innovative treatments for Lyme disease and Rosacea.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Hybrid Work Options

Professional Development Budget